Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 62 Results

Title
Intervention Indication Therapeutic Area Year Actions
Dapagliflozin for chronic kidney disease Dapagliflozin (Forxiga; BMS512148; Farxiga; dapagliflozin propanediol monohydrate) Chronic kidney disease (CKD) Cardiovascular System , Nephrology 2020 View  |  Download
Dapagliflozin for heart failure with preserved ejection fraction Dapagliflozin (Forxiga; BMS512148; Farxiga; dapagliflozin propanediol monohydrate) Heart failure (HF) Cardiovascular System 2019 View  |  Download
Daprodustat for anaemia associated with chronic kidney disease Daprodustat (GSK1278863) Anaemia Cardiovascular System , Haematology , Nephrology 2021 View  |  Download
Difelikefalin for pruritus associated with chronic kidney disease Difelikefalin (Korsuva; CR845) Pruritus Cardiovascular System , Dermatology , Nephrology 2020 View  |  Download
Empagliflozin for Chronic Heart Failure with Preserved Ejection Fraction Empagliflozin (Jardiance; DINAMO) Heart failure (HF) Cardiovascular System 2021 View  |  Download
Empagliflozin for the treatment of acute myocardial infarction to reduce heart failure and mortality Empagliflozin (Jardiance; DINAMO) Heart failure (HF) Cardiovascular System 2022 View  |  Download
Empagliflozin for treating chronic kidney disease Empagliflozin (Jardiance; DINAMO) Chronic kidney disease (CKD) Cardiovascular System , Nephrology 2022 View  |  Download
Empagliflozin for treatment of chronic heart failure with reduced ejection fraction Empagliflozin (Jardiance; DINAMO) Heart failure (HF) Cardiovascular System 2020 View  |  Download
Entresto for chronic heart failure with preserved ejection fraction Entresto; LCZ 696 (fixed dose combination: Sacubitril; Valsartan) Heart failure (HF) Cardiovascular System 2019 View  |  Download
Eplontersen for treating transthyretin amyloid cardiomyopathy Eplontersen (ION-682884;AKCEA TTR-LRx) Transthyretin amyloid cardiomyopathy Cardiovascular System 2024 View  |  Download
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications